Patents by Inventor William J. Scott

William J. Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITION OF RAF KINASE USING QUINOLYL, ISOQUINOLYL OR PYRIDYL UREAS
    Publication number: 20030207914
    Abstract: This invention relates to a group of quinolyl, isoquinolyl and pyridyl ureas, their the use in treating raf mediated diseases, and pharmaceutical compositions which contain these ureas for use in such therapy.
    Type: Application
    Filed: April 19, 2002
    Publication date: November 6, 2003
    Applicant: BAYER CORPORATION
    Inventors: Jacques Dumas, Bernd Riedl, Uday Khire, Robert N. Sibley, Holia Hatoum-Mokdad, Mary-Katherine Monahan, David E. Gunn, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood
  • Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agents
    Publication number: 20030207865
    Abstract: This invention relates to 2-arylimino heterocycles, including 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and 2-arylimino-1,3-oxazolidines, and their use in modulating progesterone receptor mediated processes, and pharmaceutical compositions for use in such therapies.
    Type: Application
    Filed: October 23, 2001
    Publication date: November 6, 2003
    Inventors: Brian R. Dixon, Cedo M. Bagi, Catherine R. Brennan, David R. Brittelli, William H. Bullock, Jinshan Chen, William L. Collibee, Robert Dally, Jeffrey S. Johnson, Harold C. E. Kluender, William F. Lathrop, Peiying Liu, Carol Ann Mase, Aniko M. Redman, William J. Scott, Klaus Urbahns, Donald J. Wolanin
  • Aryl ureas with angiogenisis inhibiting activity
    Publication number: 20030207870
    Abstract: This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.
    Type: Application
    Filed: February 11, 2003
    Publication date: November 6, 2003
    Applicant: BAYER CORPORATION
    Inventors: Jacques Dumas, William J. Scott, James Elting, Holia Hatoum-Makdad
  • omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
    Publication number: 20030181442
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: November 27, 2001
    Publication date: September 25, 2003
    Applicant: BAYER CORPORATION
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Reina Natero, Joel Renick, Robert N. Sibley
  • Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
    Publication number: 20030144278
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: October 30, 2002
    Publication date: July 31, 2003
    Applicant: BAYER CORPORATION
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Reina Natero, Joel Renick, Robert N. Sibley
  • Method and/or process for preparing omega-carboxyaryl substituted diphenyl ureas as raf kinas inhibitors
    Publication number: 20030139605
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy of the formula
    Type: Application
    Filed: February 11, 2002
    Publication date: July 24, 2003
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood
  • 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of PDE7B-mediated diseases and conditions
    Publication number: 20030119829
    Abstract: The invention relates to 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same and their use to treat or prevent diseases and conditions mediated by the phosphodiesterase enzyme 7B (PDE7B). Diseases and conditions mediated by PDE7B include osteoporosis, osteopenia and asthma.
    Type: Application
    Filed: April 29, 2002
    Publication date: June 26, 2003
    Inventors: Andreas Stolle, Donald E. Bierer, Yuanwei Chen, Dongping Fan Can, Barry Hart, Mary Katherine Monahan, William J. Scott
  • 17-Beta-hydroxysteroid dehydrogenase-II inhibitors
    Publication number: 20030087952
    Abstract: 17-beta-hydroxysteroid dehydrogenase-I1 inhibitors having the structural formula 1
    Type: Application
    Filed: September 28, 2001
    Publication date: May 8, 2003
    Inventors: Jill E. Wood, Jeremy L. Baryza, Catherine R. Brennan, Soongyu Choi, James H. Cook, Brian R. Dixon, Paul P. Ehrlich, David E. Gunn, Ian McAlexander, Peiying Liu, Derek B. Lowe, Aniko M. Redman, William J. Scott, Yamin Wang
  • Corkscrew spacer
    Patent number: 6530295
    Abstract: A spacer and method for facilitating removal of a cork from a bottle with a corkscrew. The spacer has a bottom surface that abuts the bottle, a top surface that abuts the bottom of a corkscrew, and a side opening that is sufficiently large to receive the cork. Once the corkscrew has been used to partially remove the cork, the spacer is placed around the exposed cork by pulling the body of the corkscrew away from the bottle while the screw is still inserted in the cork and inserting the spacer in the resulting space. Force is then reapplied to completely remove the cork from the bottle. One or more spacers may be attached to the corkscrew by a flexible cord for convenience. In one embodiment, a hinge mechanism interconnects a number of spacers of various thicknesses and opening sizes.
    Type: Grant
    Filed: November 6, 2001
    Date of Patent: March 11, 2003
    Inventor: William J. Scott
  • Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
    Publication number: 20020165394
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions in such therapy.
    Type: Application
    Filed: February 7, 2001
    Publication date: November 7, 2002
    Applicant: BAYER CORPORATION
    Inventors: Jacques Dumas, Bernd Riedl, Uday Khire, Jill E. Wood, Sibley N. Robert, Mary-Katherine Monahan, Joel Renick, David E. Gunn, Timothy B. Lowinger, William J. Scott, Roger A. Smith
  • Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
    Publication number: 20020137774
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: July 19, 2001
    Publication date: September 26, 2002
    Applicant: BAYER CORPORATION
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Reina Natero, Joel Renick, Robert N. Sibley
  • Paint strainer for use with paint sprayers
    Patent number: 6436286
    Abstract: A paint strainer is disclosed for use with a paint container and a pickup tube. The paint strainer comprises a mesh bag having an elastic material surrounding the opening of the bag wherein the elastic material engages the rim of the container to hold the bag in place. The bag further includes an aperture formed adjacent to the rim of the container which receives the pickup tube surrounded by an elastic band.
    Type: Grant
    Filed: February 17, 2000
    Date of Patent: August 20, 2002
    Inventor: William J. Scott
  • Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
    Publication number: 20020065296
    Abstract: This invention relates to the use of a group of heteroaryl ureas containing nitrogen in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: April 20, 2001
    Publication date: May 30, 2002
    Applicant: BAYER CORPORATION
    Inventors: Jacques Dumas, Bernd Riedl, Uday Khire, Robert N. Sibley, Holia Hatoum-Mokdad, Mary-Katherine Monahan, David E. Gunn, Timotthy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood
  • Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
    Publication number: 20020042517
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: September 10, 2001
    Publication date: April 11, 2002
    Applicant: BAYER CORPORATION
    Inventors: Khire Uday, Jacques Dumas, Bernd Riedl, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Reina Natero, Renick Joel, Robert N. Sibley
  • Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
    Patent number: 6353006
    Abstract: This invention relates to 2-arylimino heterocycles, including 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and 2-arylimino-1,3-oxazolidines, and their use in modulating progesterone receptor mediated processes, and pharmaceutical compositions for use in such therapies.
    Type: Grant
    Filed: December 3, 1999
    Date of Patent: March 5, 2002
    Assignee: Bayer Corporation
    Inventors: Brian R. Dixon, Cedo M. Bagi, Catherine R. Brennan, David R. Brittelli, William H. Bullock, Jinshan Chen, William L. Collibee, Robert Dally, Jeffrey S. Johnson, Harold C. E. Kluender, William F. Lathrop, Peiying Liu, Carol Ann Mase, Anikó M. Redman, William J. Scott, Klaus Urbahns, Donald J. Wolanin
  • Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
    Publication number: 20010034447
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: February 2, 2001
    Publication date: October 25, 2001
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy P. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Rena Natero, Joel Renick, Robert N. Sibley
  • Omega-carboxyaryl substituted disphenyl ureas as raf kinase inhibitors
    Publication number: 20010027202
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: February 2, 2001
    Publication date: October 4, 2001
    Inventors: Bernd Riedl, Jaques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Reina Natero, Joel Renick, Robert N. Sibley
  • Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
    Publication number: 20010016659
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: February 2, 2001
    Publication date: August 23, 2001
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Rena Natero, Joel Renick, Robert N. Sibley
  • omega-carboxyyaryl substituted diphenyl ureas as raf kinase inhibitors
    Publication number: 20010011136
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: February 2, 2001
    Publication date: August 2, 2001
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Reina Natero, Joel Renick, Robert N. Sibley
  • Omega-carboxyaryl subsituted diphenyl ureas as raf kinase inhibitors
    Publication number: 20010011135
    Abstract: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: February 2, 2001
    Publication date: August 2, 2001
    Inventors: Bernd Riedl, Jacques Dumas, Uday Khire, Timothy B. Lowinger, William J. Scott, Roger A. Smith, Jill E. Wood, Mary-Katherine Monahan, Reina Natero, Joel Renick, Robert N. Sibley